Bank of New York Mellon
CGEM icon

Bank of New York Mellon’s Cullinan Oncology CGEM Stock Holding History

Bank of New York Mellon’s Portfolio CGEM Stock Details CGEM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.11M Buy
171,031
+27,323
+19% +$406K ﹤0.01% 2705
2026
Q1 		$2.04M Sell
143,708
-1,219
-0.8% -$15.7K ﹤0.01% 2801
2025
Q4 		$1.5M Sell
144,927
-4,998
-3% -$45.1K ﹤0.01% 3009
2025
Q3 		$889K Sell
149,925
-5,956
-4% -$43.6K ﹤0.01% 3273
2025
Q2 		$1.17M Buy
155,881
+19,467
+14% +$156K ﹤0.01% 3051
2025
Q1 		$1.03M Sell
136,414
-1,202
-0.9% -$11.5K ﹤0.01% 3047
2024
Q4 		$1.68M Sell
137,616
-730
-0.5% -$10.5K ﹤0.01% 2839
2024
Q3 		$2.32M Buy
138,346
+349
+0.3% +$6.19K ﹤0.01% 2682
2024
Q2 		$2.41M Buy
137,997
+43,757
+46% +$932K ﹤0.01% 2693
2024
Q1 		$1.61M Sell
94,240
-4,763
-5% -$73.6K ﹤0.01% 2888
2023
Q4 		$1.01M Buy
99,003
+1,844
+2% +$16.3K ﹤0.01% 3183
2023
Q3 		$879K Buy
97,159
+9,989
+11% +$104K ﹤0.01% 3231
2023
Q2 		$938K Sell
87,170
-9,070
-9% -$96.3K ﹤0.01% 3228
2023
Q1 		$985K Sell
96,240
-12,771
-12% -$141K ﹤0.01% 3137
2022
Q4 		$1.15M Buy
109,011
+3,133
+3% +$38.1K ﹤0.01% 3128
2022
Q3 		$1.36M Buy
105,878
+13,574
+15% +$183K ﹤0.01% 3056
2022
Q2 		$1.18M Sell
92,304
-880
-0.9% -$9.98K ﹤0.01% 3131
2022
Q1 		$975K Sell
93,184
-2,239
-2% -$30.3K ﹤0.01% 3334
2021
Q4 		$1.47M Buy
95,423
+15,259
+19% +$304K ﹤0.01% 3165
2021
Q3 		$1.81M Buy
80,164
+40,537
+102% +$1.08M ﹤0.01% 3043
2021
Q2 		$1.02M Buy
39,627
+4,802
+14% +$148K ﹤0.01% 3408
2021
Q1 		$1.45M Buy
+34,825
New +$1.41M ﹤0.01% 3111

Other funds holding CGEM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
TFCP
Twin Focus Capital Partners Boston, Massachusetts $983M AUM 37.07% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return
Swiss National Bank
Swiss National Bank Zurich, Switzerland $191B AUM 45.21% 1-Year Est. Return
TE
Tema ETFs New York $3.09B AUM 72.72% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Bank of New York Mellon's CGEM Position: Q2 2026 in Review

Bank of New York Mellon increased its Cullinan Oncology (CGEM) stake by 19% in Q2 2026, buying an estimated $406K and bringing the position to 171,031 shares worth $3.11M. The position accounts for ﹤0.01% of the portfolio, ranked #2705.

Bank of New York Mellon first reported a position in CGEM in Q1 2021 and has held it in 22 quarters since. 57 funds tracked by Wall St. Rank hold CGEM as of Q2 2026.

  • Bank of New York Mellon held 171,031 shares of Cullinan Oncology worth $3.11M as of Q2 2026.
  • Bank of New York Mellon bought 27,323 Cullinan Oncology shares in Q2 2026, an estimated $406K.
  • Cullinan Oncology made up ﹤0.01% of Bank of New York Mellon's portfolio in Q2 2026, its #2705 holding.
  • Bank of New York Mellon first reported a position in Cullinan Oncology in Q1 2021 and has held it in 22 quarters since.
  • 57 funds tracked by Wall St. Rank held Cullinan Oncology as of Q2 2026.

Based on Bank of New York Mellon's 13F filing for Q2 2026, filed 6 Aug 2026.